Expensify CEO Barrett sells shares worth $99,908

Published 25/02/2025, 14:54
Expensify CEO Barrett sells shares worth $99,908

David Michael Barrett, Chief Executive Officer of Expensify , Inc. (NASDAQ:EXFY), recently sold 30,093 shares of the company’s Class A Common Stock. The transaction, which took place on February 21, 2025, was part of a pre-established Rule 10b5-1 trading plan. The sale comes as the stock has experienced significant volatility, with a -10.44% decline over the past week despite a strong 76% gain over the last year. According to InvestingPro analysis, the company appears undervalued based on its Fair Value metrics. The shares were sold at a weighted average price of $3.32, with individual sale prices ranging from $3.25 to $3.48. Following this sale, Barrett retains direct ownership of 185,289 shares and indirect ownership of 1,917,279 shares through Barrett Trust LLC. This sale amounted to a total value of $99,908. With Expensify’s market capitalization at $341.62 million and its upcoming earnings report scheduled for February 27, 2025, InvestingPro subscribers can access comprehensive insider trading analysis and 12 additional ProTips to better understand the company’s financial position.

In other recent news, JMP Securities has downgraded Expensify Inc from a Market Outperform to a Market Perform rating. This adjustment follows a significant surge in Expensify’s stock price, which has exceeded JMP Securities’ previous price target of $3.25. The stock’s performance has been notable, with a year-to-date increase of 38%, surpassing the Russell 3000 index’s 25% rise. Since August 9, Expensify’s stock has jumped 94%, compared to a 13% gain in the Russell 3000 during the same period. The downgrade reflects the company’s current valuation meeting JMP Securities’ benchmarks. The decision was made after virtual investor meetings with Expensify’s CFO and Head of Investor Relations, highlighting the company’s strong market performance. JMP Securities’ decision to downgrade does not include additional insights into Expensify’s financial health or future outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.